Gene Review:
ATL1 - atlastin GTPase 1
Homo sapiens
Synonyms:
AD-FSP, Atlastin-1, Brain-specific GTP-binding protein, FSP1, GBP-3, ...
- Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. Zhu, P.P., Patterson, A., Lavoie, B., Stadler, J., Shoeb, M., Patel, R., Blackstone, C. J. Biol. Chem. (2003)
- Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Dürr, A., Camuzat, A., Colin, E., Tallaksen, C., Hannequin, D., Coutinho, P., Fontaine, B., Rossi, A., Gil, R., Rousselle, C., Ruberg, M., Stevanin, G., Brice, A. Arch. Neurol. (2004)
- Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28). Bouslam, N., Benomar, A., Azzedine, H., Bouhouche, A., Namekawa, M., Klebe, S., Charon, C., Durr, A., Ruberg, M., Brice, A., Yahyaoui, M., Stevanin, G. Ann. Neurol. (2005)
- De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Rainier, S., Sher, C., Reish, O., Thomas, D., Fink, J.K. Arch. Neurol. (2006)
- Characterization of a novel SPG3A deletion in a French-Canadian family. Meijer, I.A., Dion, P., Laurent, S., Dupré, N., Brais, B., Levert, A., Puymirat, J., Rioux, M.F., Sylvain, M., Zhu, P.P., Soderblom, C., Stadler, J., Blackstone, C., Rouleau, G.A. Ann. Neurol. (2007)
- Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Zhao, X., Alvarado, D., Rainier, S., Lemons, R., Hedera, P., Weber, C.H., Tukel, T., Apak, M., Heiman-Patterson, T., Ming, L., Bui, M., Fink, J.K. Nat. Genet. (2001)
- Survey of the fragile X syndrome CGG repeat and the short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American population. Crawford, D.C., Schwartz, C.E., Meadows, K.L., Newman, J.L., Taft, L.F., Gunter, C., Brown, W.T., Carpenter, N.J., Howard-Peebles, P.N., Monaghan, K.G., Nolin, S.L., Reiss, A.L., Feldman, G.L., Rohlfs, E.M., Warren, S.T., Sherman, S.L. Am. J. Hum. Genet. (2000)
- Autosomal dominant familial spastic paraplegia: reduction of the FSP1 candidate region on chromosome 14q to 7 cM and locus heterogeneity. Gispert, S., Santos, N., Damen, R., Voit, T., Schulz, J., Klockgether, T., Orozco, G., Kreuz, F., Weissenbach, J., Auburger, G. Am. J. Hum. Genet. (1995)
- SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development. Zhu, P.P., Soderblom, C., Tao-Cheng, J.H., Stadler, J., Blackstone, C. Hum. Mol. Genet. (2006)
- Characterization of Fibroblast-specific Protein 1 in Pulmonary Fibrosis. Lawson, W.E., Polosukhin, V.V., Zoia, O., Stathopoulos, G.T., Han, W., Plieth, D., Loyd, J.E., Neilson, E.G., Blackwell, T.S. Am. J. Respir. Crit. Care Med. (2005)
- SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. Wilkinson, P.A., Hart, P.E., Patel, H., Warner, T.T., Crosby, A.H. J. Neurol. Sci. (2003)
- Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia. Hedera, P., Fenichel, G.M., Blair, M., Haines, J.L. Arch. Neurol. (2004)
- A founder effect and mutational hot spots may contribute to the most frequent mutations in the SPG3A gene. Namekawa, M., Nelson, I., Ribai, P., Dürr, A., Denis, E., Stevanin, G., Ruberg, M., Brice, A. Neurogenetics (2006)
- Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. Forbes, M.S., Thornhill, B.A., Park, M.H., Chevalier, R.L. Am. J. Pathol. (2007)
- Involvement of the Rho-kinase/myosin light chain kinase pathway on human monocyte chemotaxis induced by ATL-1, an aspirin-triggered lipoxin A4 synthetic analog. Simões, R.L., Fierro, I.M. J. Immunol. (2005)
- Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly. Cezar-de-Mello, P.F., Nascimento-Silva, V., Villela, C.G., Fierro, I.M. Oncogene (2006)
- Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Nishitani, Y., Iwano, M., Yamaguchi, Y., Harada, K., Nakatani, K., Akai, Y., Nishino, T., Shiiki, H., Kanauchi, M., Saito, Y., Neilson, E.G. Kidney Int. (2005)
- Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. Sanderson, C.M., Connell, J.W., Edwards, T.L., Bright, N.A., Duley, S., Thompson, A., Luzio, J.P., Reid, E. Hum. Mol. Genet. (2006)
- Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Nascimento-Silva, V., Arruda, M.A., Barja-Fidalgo, C., Villela, C.G., Fierro, I.M. Am. J. Physiol., Cell Physiol. (2005)
- SPG3A: An additional family carrying a new atlastin mutation. Tessa, A., Casali, C., Damiano, M., Bruno, C., Fortini, D., Patrono, C., Cricchi, F., Valoppi, M., Nappi, G., Amabile, G.A., Bertini, E., Santorelli, F.M. Neurology (2002)
- A missense mutation in the coiled-coil domain of the KIF5A gene and late-onset hereditary spastic paraplegia. Lo Giudice, M., Neri, M., Falco, M., Sturnio, M., Calzolari, E., Di Benedetto, D., Fichera, M. Arch. Neurol. (2006)
- Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Rossini, M., Cheunsuchon, B., Donnert, E., Ma, L.J., Thomas, J.W., Neilson, E.G., Fogo, A.B. Kidney Int. (2005)